Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · IEX Real-Time Price · USD
24.62
+0.83 (3.49%)
At close: May 17, 2024, 4:00 PM
24.75
+0.13 (0.53%)
After-hours: May 17, 2024, 7:58 PM EDT
Beam Therapeutics Employees
Beam Therapeutics had 507 employees on December 31, 2022. The number of employees increased by 166 or 48.68% compared to the previous year.
Employees
507
Change (1Y)
166
Growth (1Y)
48.68%
Revenue / Employee
$711,856
Profits / Employee
-$265,751
Market Cap
2.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 507 | 166 | 48.68% |
Dec 31, 2021 | 341 | 160 | 88.40% |
Dec 31, 2020 | 181 | 63 | 53.39% |
Dec 31, 2019 | 118 | 31 | 35.63% |
Dec 31, 2018 | 87 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Evotec SE | 4,952 |
UFP Technologies | 3,093 |
Zai Lab | 2,175 |
Novavax | 1,543 |
Galapagos NV | 1,123 |
Agios Pharmaceuticals | 386 |
Catalyst Pharmaceuticals | 167 |
BEAM News
- 4 days ago - Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress - GlobeNewsWire
- 10 days ago - Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference - GlobeNewsWire
- 11 days ago - Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) - GlobeNewsWire
- 2 months ago - Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences - GlobeNewsWire
- 2 months ago - Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones - GlobeNewsWire
- 3 months ago - Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire
- 4 months ago - Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated Milestones - GlobeNewsWire